<h2>Exploring the Role of Cannabinoids in Sleep Health</h2>
<p>On August 13, 2025, Dr. Dustin Sulak, a renowned osteopathic general practitioner and founder of the cannabis education platform, Healer, delivered an insightful webinar focusing on cannabinoids' impact on sleep and related disorders. With a series of seven studies, Dr. Sulak delved into the nuances of cannabinoids such as THC and CBD, particularly regarding sleep architecture, sleep apnea, and inflammation. Canna Daily News offers an overview of the initial three studies discussed in this informative session.</p>
<h3>Study Insights on Cannabinoid Sleep Impact</h3>
<p>The first study, titled "Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia," published in the Journal of Sleep Research in July 2025, examined the effects of a single oral dose containing 10 mg THC and 200 mg CBD on 20 patients diagnosed with insomnia. Findings revealed a decrease in total sleep time and REM sleep without affecting next-day alertness or cognitive performance. Dr. Sulak cautioned that the combination, particularly the high CBD dose, might have contributed to disrupted sleep, emphasizing the need for personalized cannabis treatments for optimal sleep architecture.</p>
<h3>Enhancing Sleep and Mood with Cannabinoids</h3>
<p>The second study, "Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia," published in Health Science Reports in February 2025, explored a more nuanced cannabinoid approach. Administering a blend of THC, CBN, CND, and a terpene-rich formula significantly improved sleep quality and mood in 20 adult participants over a ten-day period. Highlighting the potential synergy between cannabinoids and terpenes, Dr. Sulak emphasized the importance of careful formulation, while questioning the modest inclusion of CBN and its comparability to THC.</p>
<h3>Topical CBD and Its Therapeutic Potential</h3>
<p>The final study, "Expanding the Therapeutic Profile of Topical Cannabidiol in Temporomandibular Disorders," published in Pharmaceuticals, demonstrated promising results for CBD's topical application. Over a 30-day trial, two CBD gel concentrations applied intraorally showed significant improvements in sleep, migraine symptoms, and muscle tension among participants experiencing bruxism-related pain. Dr. Sulak suggests that utilizing CBD in such targeted applications could offer a novel approach to managing sleep disturbances without compromising systemic absorption, favoring a more localized therapeutic impact.</p>
<p>Stay tuned to Canna Daily News as we further explore these groundbreaking insights in the field of cannabis and health. Additional findings from Dr. Sulak's webinar will be shared shortly.</p>
<p>#CannabisNews #CBDResearch #SleepHealth #CannabinoidsInFocus #CannaDailyInsight</p>